Results per Page:
Fred Hutch researchers receive Prostate Cancer Foundation Young Investigator Awards
Three-year projects explore epigenetics to make new therapies or make existing therapies work better
Dr. Toshio Tsukiyama receives the inaugural David and Deborah Lycette Endowed Chair for Cancer Research
Fred Hutch endowed chair to drive fundamental discovery into how cells function
Dr. Hans-Peter Kiem receives ASGCT mentorship award
Fred Hutch gene therapy expert views mentorship as a lifelong commitment
Las condiciones precancerosas hacen que el estómago sea susceptible a infecciones bacterianas
Del Laboratorio Salama, Departamento de Biología Humana
Evolution of a stomach bug: Helicobacter pylori sticks around to survive
From the Salama Lab, Human Biology Division
Boosting CAR-T cell endurance to take on solid tumors
From the Srivastava Lab, Human Biology Division
Fred Hutch study dramatically expands therapeutic range of approved kinase drugs
Large-scale analysis reveals new uses for existing therapies across cancer types and non-cancer diseases
Is there a way to boost immunotherapy response?
American Cancer Society grant will fund new analysis of how advanced melanoma evades the immune system
Answering WHO’s call with a new way to track how well we’re fighting the flu
Fred Hutch researchers’ immunity data informs global vaccine updates
Fred Hutch researchers receive prestigious R01 awards
NIH-funded awards will support multi-year investigations into HIV reservoirs, biomarkers of vaccine efficacy and how PrEP influences antibody pharmacokinetics
Does solar jet lag contribute to liver cancer?
Fred Hutch researcher will use American Cancer Society grant to determine if circadian disruption increases risk for hepatocellular carcinoma
Confused about cancer? 1.800.4.CANCER is here to help
The taxpayer-supported National Cancer Institute contact center is based at Fred Hutch Cancer Center
A swing and a swing and a hit: DNA control of RecBCD conformation and activity
From the Smith Lab, Basic Sciences Division
How chronic graft-versus-host disease unfolds ten years after transplant
From the Lee Lab, Clinical Research Division
Fred Hutch brings together rare cancer community
Patients and caregivers share frustrations, practical realities of rare cancer life at TRACER program’s first education symposium
A group retreat model for psilocybin therapy in cancer care
From Dr. Anthony Back and the Gooley Group, Clinical Research Division
How Fred Hutch scientists tackle world’s top infectious killer, TB
Expertise in immunology and biostatistics underpin foundational work in tuberculosis vaccines, biomarkers and pathology that could usher in a new era
Fred Hutch collaboration reveals molecular vulnerability in rare childhood brain cancer
Researchers uncover a weak link in tumors driven by a notorious gene fusion that could be targeted with a drug